Is LITE a buy, hold, or sell?
LITE carries a valuation grade of Buy. The trailing P/E of 138.8 sits 334% above the Technology sector median of 32.0x — a premium that demands sustained earnings delivery. Our discounted cash flow model produces an intrinsic range of $500–$1,160 — implying a +6% margin of safety at the current price of $785.90. The width of the DCF range reflects genuine uncertainty in the terminal growth rate assumption: the correct framework is a probability-weighted distribution over scenarios, not a single point estimate. See the DCF valuation framework for full methodology.
With a 12% beat rate on recent quarters, earnings predictability has been mixed. The most recent quarter delivered a 4.6% earnings surprise. Analyst estimate revisions are trending upward.
What are LITE's key risk factors?
With a beta of 1.48, LITE exhibits an above-market risk profile relative to the broad market. The 95th-percentile CVaR of -19.3% on a one-month horizon should inform position sizing directly: at a 10% portfolio weight, this tail event contributes approximately 1.9% of total portfolio loss in the worst 5% of months. Net margins stand at 17.7%. Return on equity of 22.8% suggests solid capital efficiency. Leverage is moderate with debt-to-equity at 111%.
A put/call ratio of 0.99 indicates roughly balanced sentiment in the options market. Implied volatility of 81.3% is below realized volatility of 88.4%, potentially making options relatively cheap. Insiders have been net sellers to the tune of $104.4M recently. While routine dispositions are common, the magnitude bears watching. Short interest of 13.2% of float is elevated, reflecting meaningful bearish positioning.
How does LITE fit in a diversified portfolio?
At typical HENRY portfolio weights — 10–20% of the equity allocation — LITE carries a beta of 1.48, meaning it amplifies broad market moves proportionally. The appropriate weight is not a function of conviction alone, but of the full covariance structure across all holdings. See the Ledoit-Wolf covariance framework for the methodology behind these calculations.
Among closely correlated names, LITE shows the strongest co-movement with AVGO (0.45), MRVL (0.36), ANET (0.33). Investors seeking diversification should note these correlation dynamics when constructing multi-asset portfolios.
True portfolio risk is a function of the full covariance structure across all holdings — not individual stock metrics. The Portfolio Health Check quantifies this at the portfolio level: it surfaces hidden concentration, marginal CVaR contributions, and the degree to which your overall allocation deviates from an optimal risk-adjusted mandate. The LITE analysis here is a single node in that larger structure.
For the portfolio construction framework underpinning LITE’s position sizing and conviction rating — including IPS guardrails, Black-Litterman allocation, and CVaR constraints — see: Investment Policy Statement Framework →
